February kicks off with a big surprise as the US Supreme Court loses an Iconic figure with significant impact on today’s Antitrust landscape. Authorities around the world continue to grapple with the implications of disruptive technologies and the digital age, with some possible lessons for companies and authorities alike. Join us as we look back at February’s leap into the antitrust trail.
A Quick Take on Justice Scalia’s Legacy on Antitrust Law
The late Justice Antonin Scalia was not the biggest fan of antitrust law. As he famously quipped during his Senate confirmation hearing: “In law school, I never understood [antitrust law]. I later found out, in reading the writings of those who now do understand it, that I should not have understood it because it did not make any sense then.”
Amar Naik(Antitrust Law Blog)
The Economics of Pay To Delay Deals
On Friday 12 February 2016, the UK’s Competition and Markets Authority (CMA) issued drug manufacturer GlaxoSmithKline (GSK) a £37.6 million fine with an additional £7.4 million imposed on partner drug manufacturers for engaging in a so-called ‘pay for delay’ or ‘pay to delay’ deal that lasted from 2001 to 2004 for its antidepressant drug Seroxat.
Farasat Bokhari (Competition Policy News)
Antonin Scalia’s telecommunications legacy
Before there was U.S. Supreme Court Associate Justice Antonin Scalia, or federal Judge Antonin Scalia of the U.S. Court of Appeals for the District of Colu…